|
2024
|
Invention
|
Polymorphs of a jak1/tyk2 inhibitor and uses thereof. Provided herein are solid forms, for exampl... |
|
|
Invention
|
Compounds and processes for the preparation of jak inhibitors. Described are improved processes f... |
|
2023
|
Invention
|
Azetidinyl pyrimidines and uses thereof as jak inhibitors. Provided herein are compounds useful a... |
|
2022
|
Invention
|
Ophthalmic pharmaceutical compositions and uses thereof |
|
|
Invention
|
Ophthalmic pharmaceutical compositions and uses thereof. Provided herein are ophthalmic pharmaceu... |
|
|
Invention
|
Synthetic intermediates and improved processes for preparing rock inhibitors. Provided herein are... |
|
|
Invention
|
Janus kinase inhibiting pyrazole compounds and uses thereof. Provided herein are pyrazole compoun... |
|
|
Invention
|
Azetidinyl pyrimidines and uses thereof. Provided herein are azetidine pyrimidine compounds. In p... |
|
|
Invention
|
Pharmaceutical preparation. Provided herein are solid forms of alpha-(aminomethyl)-4-(hydroxymeth... |
|
|
Invention
|
Stable isoquinoline-corticosteroid conjugates and uses thereof. Provided herein are compounds and... |
|
|
Invention
|
Implant delivery device. Implant delivery devices, methods of device assembly and methods of usin... |
|
2021
|
Invention
|
Intraocular implant for drug delivery. A medical implant is disclosed. The medical implant includ... |
|
|
Invention
|
Treatments. Described herein are compounds, combinations of compounds, compositions, formulations... |
|
|
Invention
|
Pharmaceutical preparation. Provided herein are pharmaceutical preparations comprising an aqueous... |
|
2020
|
Invention
|
Heterobicyclic carboxamides and uses thereof. Provided herein are heterobicyclic cyclopropanecarb... |
|
|
Invention
|
Ophthalmic composition for treating dry eye and symptoms thereof.
It is provided an ophthalmic c... |
|
|
Invention
|
Pharmaceutical compositions for treating ocular diseases or disorders. Provided herein are pharma... |
|
|
Invention
|
Thienyl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are thienyl cyclopropyl-... |
|
|
Invention
|
Compounds, compositions and methods for treatment of myopia. Provided herein are 8-methyl-8-azabi... |
|
2019
|
Invention
|
Aryl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are amino isoquinolinyl ami... |
|
|
Invention
|
Isoquinoline-steroid conjugates and uses thereof. Provided herein are compounds and pharmaceutica... |
|
|
Invention
|
Mono-(acid) salts of 6-aminoisoquinolines and uses thereof. Provided herein are mono-(acid) salts... |
|
|
Invention
|
Amino-benzoisothiazole and amino-benzoisothiadiazole amide compounds. Provided herein are amino-b... |
|
2018
|
Invention
|
Aryl cyclopropyl-amino-isoquinolinyl amide compounds. Provided herein are arylcyclopropyl amino-i... |
|
2017
|
Invention
|
Methods for the preparation of 6-aminoisoquinoline. Described are methods for the preparation of ... |
|
|
Invention
|
Implant applicators. An intracameral injector needle having a substantially cylindrical body defi... |
|
|
Invention
|
Ophthalmic compositions. The present disclosure provides an ophthalmic composition comprising 4-(... |
|
|
Invention
|
Beta-amino-isoquinolinyl amide compounds. Disclosed are alpha-axyl-beta-axmno isoquinoline amide ... |
|
2016
|
Invention
|
Intravitreal drug delivery systems for the treatment of ocular conditions. The disclosure teaches... |
|
|
Invention
|
Ocular protein delivery. The disclosure teaches methods of making ocular, sustained release pharm... |
|
|
Invention
|
Implant applicators and methods of administering implants. Embodiments described herein rel... |
|
2015
|
Invention
|
Process for the preparation of kinase inhibitors and intermediates thereof. Described are process... |
|
|
Invention
|
Process for the preparation of kinase inhibitors and intermediates thereof. Described are p... |
|
2014
|
Invention
|
Isoquinoline compounds for the treatment of ocular diseases. Described herein are compounds and c... |
|
|
Invention
|
Combination therapy. Described herein are compounds and compositions for treating glaucoma and/or... |
